PrEP Overview

The PrEP REP Project

 

 

The PrEP Audio Visual Representation (PrEP REP) Project is a multiagency collaborative supported by a grant from Gilead Sciences Inc. that developed a video that animates how PrEP protects people against HIV and reinforces why adherence to the medical regimen is so important.

Click here—or on the image above *—for the video (English/español): "What is PrEP?" | "¿Qué es PrEP?"  ¹,²

The collaborative was led by K. Rivet Amico, PhD, University of Michigan School of Public Health, and Sybil G. Hosek, PhD, Stroger Hospital of Cook County, Chicago.

Daily, oral pre-exposure prophylaxis (PrEP) using the antiretroviral drugs tenofovir and emtricitabine was approved by the US Food and Drug Administration in 2012, but not many people know about it. This video is part of a campaign to broaden awareness.

* Also available on Vimeo from Pre-Exposure Prophylaxis.

Other Resources

¹ PrEP REP Project is a multiagency collaborative that includes the University of Connecticut, University of Michigan and Stroger Hospital of Cook County, Chicago, supported by a grant from Gilead Sciences Inc.
² Also available on Vimeo from Pre-Exposure Prophylaxis